A new high-throughput platform screens dozens of nanoparticle designs in living systems to identify those that reach tumour mitochondria, enabling more precise and effective cancer therapies ...

By tagging nanoparticles with unique DNA "barcodes", the team was able to track and compare dozens of designs simultaneously ...

Entropy gets a bad rap. Typically associated with randomness and chaos, it can also correlate with freedom and diversity.

Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S.

The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...

Biologics License Application (BLA) for INO-3107 actively being reviewed under the accelerated approval program by the U.S. Food and Drug Administration (FDA) with ...

Data highlight advancements across ElevateBio's targeted gene insertion platform, powered by retrotransposon and machine learning-optimized ...

SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced data from two oral and one e-poster presentation, focusing on CSCC, at the 83rd Society for ...

Nearly three decades ago, national headlines told a dramatic story: "Individual Inc.'s CEO, Amram, Takes Leave, and Stock Drops." -- Wall Street Journal"Founder of Individual takes leave and shares ...

Pumpkinseed founders Jennifer Dionne, Jack Hu, and Nhat Vu discuss their nanophotonic chip platform that promises label-free, ...

The biotech landscape of 2026 is defined by a convergence of forces that are no longer theoretical but are actively reshaping how drugs are discovered, tested, and approved. From the FDA's formal ...

In 2026, biotech is delivering tangible clinical milestones, from the first AI-designed drug showing Phase IIa efficacy to the recovery of the first base-edited baby. Advances in in vivo CAR-T, ...